TMCnet News
The New ICH GCP E6 R2 Guideline Course (London, United Kingdom - February 27th, 2018) - Research and MarketsThe "The New ICH GCP E6 R2 Guideline" conference has been added to Research and Markets' offering With the new ICH GCP E6 Revision 2 changes now finalised and needing to be implemented, it is important for organisations running clinical trials to understand the changes, the reasons behind them, and how they will be affected. The new guideline includes a number of hot GCP inspection topics which are also covered in a number of other EU and FDA guidelines and documents, such as risk-based approaches for running clinical trials. These new approaches are aimed at increasing efficiency and reducing costs of clinical trials. This course will cover these new requirements for running clinical trials, evaluate the changes and discuss how to implement these for sponsors, CROs and study sites. This will enable you to meet the new international GCP standad to ensure the acceptance of clinical trial data by the regulatory authorities internationally including the European Union (EU), Japan, the United States, Canada and Switzerland. Benefits of attending
Agenda:
For more information about this conference visit https://www.researchandmarkets.com/research/md32lv/the_new_ich_gcp
View source version on businesswire.com: http://www.businesswire.com/news/home/20171005005625/en/ |